申请人:Beecham Group Limited
公开号:US03984565A1
公开(公告)日:1976-10-05
A pharmaceutical composition is produced which is useful for treating allergic conditions in humans which comprises an anti-allergenic amount of a compound of the formula: ##SPC1## Or a pharmaceutically acceptable salt or ester thereof, wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are the same or different and each is hydrogen, alkyl, alkoxy, aryl, aralkyl or halogen or any two of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 taken together, with the carbon atoms to which they are attached, form a phenyl, cyclohexyl or cyclohexenyl ring, in combination with a pharmaceutically acceptable carrier.
生产了一种制剂,用于治疗人体内的过敏症状,该制剂包含以下化合物的抗过敏剂量:##SPC1## 或其药学上可接受的盐或酯,其中R.sub.1,R.sub.2,R.sub.3和R.sub.4相同或不同,每个为氢,烷基,烷氧基,芳香族,芳基烷基或卤素,或者R.sub.1,R.sub.2,R.sub.3和R.sub.4中的任意两个与它们所连接的碳原子结合形成苯基,环己基或环己烯基环,与药学上可接受的载体结合使用。